Aims and approaches of Web-RADR: A consortium ensuring reliable ADR reporting via mobile devices and new insights from social media

Expert Opinion on Drug Safety

Volumn 14, Issue 12, 2015, Pages 1845-1853

  Ghosh, Rajesh ^a   Lewis, David ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Innovative Medicines Innovation; mobile reporting; real time data; social media

Indexed keywords

CLINICAL TRIAL (TOPIC); DRUG SURVEILLANCE PROGRAM; DRUG USE; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL INFORMATICS; MOBILE APPLICATION; MOBILE PHONE; MULTIMEDIA; PRESCRIPTION; REVIEW; SOCIAL INTERACTION; SOCIAL MEDIA; SYSTEMATIC REVIEW (TOPIC); VELOCITY; WEB RECOGNIZING ADVERSE DRUG REACTION; ADVERSE DRUG REACTION; ETHICS; EUROPEAN UNION; INTERNET; LEGISLATION AND JURISPRUDENCE; SMARTPHONE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EUROPEAN UNION; HUMANS; INTERNET; PHARMACOVIGILANCE; SMARTPHONE; SOCIAL MEDIA;

EID: 84951906467     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2015.1096342     Document Type: Review

References (12)

1. Baines RJ, Langelaan M, de Bruijne MC, et al. Changes in adverse event rates in hospitals over time: A longitudinal retrospective patient record review study. BMJ 2013;22(4):290-8
2. Classen DC, Resar R, Griffin F, et al. Global trigger tool shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff (Millwood) 2011;30(4):581-9
3. Hazell L, Shakir S. Under-reporting of adverse drug reactions a systematic review. Drug Saf 2006;29(5):385-96
4. Levinston D Hospital incident reporting systems do not capture most patients harm. Proc Am Thorac Soc 2013;1):3-8
5. Silverman Ed. Forbes-Tweet this: Pharma still fails to embrace social media, 2014
6. Shojania K, Thomas E. Trends in adverse events over time: why are we not improving? BMJ 2013;22(4):273-7
7. Web-RADR project documents including description of work
8. Avery AJ, Anderson C, Bond CM, et al. Evaluation of patient reporting of adverse drug reactions to the UK Yellow Card Scheme: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess 2011;15(20):1-234
9. Hansen M, Birkinshaw J. The innovation value chain. Harv Bus Rev 2007;85(6):121-30, 142
10. Zegers M, de Bruijne MC, Wagner C, et al. Adverse events and potentially preventable deaths in Dutch hospitals: results of a retrospective patient record review study. Qual Saf Health Care 2009;18(4):297-302
11. Hammond M L. Moores Law: The First 70 Years. Semiconductor International; 2004
12. Davey S, Rutten M. A Comparison of detection performance for several track-before-detect algorithms, 2008